Pharmaceutical News

RSS

Efficacy of BNT162b2 vaccine against SARS-CoV-2 Omicron sublineages and Deltacron

In a recent study posted to the bioRxiv* pre-print server, researchers at the University of Texas Medical Branch, Pfizer Vaccines Research & Development and BioNTech assessed the neutralization titers of sera from individuals vaccinated with the BNT162b2 coronavirus disease 2019 (COVID-19) vaccine and previously infected with the Omicron sublineage BA.1.

10 Jun 2022

Study finds Moderna COVID vaccine efficacy peaks at 94% after 120 days

A recent research letter posted to the JAMA Network Open assessed the durability of immunity conferred by the coronavirus disease 2019 (COVID-19) messenger ribonucleic acid (mRNA)-1273 vaccine.

10 Jun 2022

Safety and efficacy of tixagevimab–cilgavimab in preventing severe COVID

In a recent study published in the Lancet, researchers evaluated the safety and efficacy of tixagevimab–cilgavimab, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing monoclonal antibody (mAb) combination in patients with mild to moderate coronavirus disease 2019 (COVID-19).

8 Jun 2022

Molnupiravir reduces hospitalizations and deaths in at-risk, unvaccinated adults with COVID

In a recent phase III study published in the New England Journal of Medicine, researchers demonstrated that oral molnupiravir was effective in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) therapy among non-vaccinated, non-hospitalized adults at-risk for severe illness.

8 Jun 2022

OpenSAFELY study shows the effectiveness of Pfizer COVID booster doses

In a recent study posted to the medRxiv pre-print server, researchers assessed the effectiveness of the Pfizer–BioNTech BNT162b2 coronavirus disease 2019 (COVID-19) vaccine in the seven million United Kingdom (UK) adults who were eligible to receive booster shots between 16 September and 16 December 2021.

7 Jun 2022

Study finds added benefits of molnupiravir for non-hospitalized COVID-19 patients

In a recent investigation published in the Annals of Internal Medicine journal, scientists demonstrated the positive impacts of molnupiravir among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients and the healthcare sector apart from lowering disease-linked deaths and hospitalizations in at-risk cohorts.

7 Jun 2022

Inequalities found in oral anticoagulant prescribing to reduce stroke risk in atrial fibrillation patients

There are racial and socioeconomic inequalities in the prescribing of oral anticoagulants to reduce stroke risk in people with atrial fibrillation, according to a new study conducted in the UK and publishing June 7th in the open-access journal PLOS Medicine by Alyaa Ajabnoor of the University of Manchester, United Kingdom, and colleagues.

7 Jun 2022

Manufacturers and suppliers influence how pharmacies buy, distribute opioid prescriptions, study finds

In today's post-pandemic world, strained global supply chains have emerged as a new norm. But in the case of prescription opioids, namely oxycodone and hydrocodone in the early 2000s, that supply chain flowed freely without any kinks.

7 Jun 2022

Misinformation clouds America’s most popular emergency contraception

A brand of specialty mozzarella cheeses. A collection of natural-gas storage terminals. And America’s top-selling emergency contraception.

7 Jun 2022

California wants to slash insulin prices by becoming a drugmaker. Can it succeed?

California is diving into the prescription drug business, attempting to achieve what no other state has done: produce its own brand of generic insulin and sell it at below-market prices to people with diabetes like Sabrina Caudillo.

7 Jun 2022

New FR-targeting, micropinocytosis-mediated bioconjugate attacks K-Ras mutant pancreatic cancer

Often undetected until it has progressed to an advanced stage, pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer.

6 Jun 2022

Safety and efficacy of SCB-2019 COVID vaccine candidate as a ChAdOx1-S booster

In a recent study posted to the medRxiv* pre-print server, researchers evaluated the immunogenicity of booster doses of alum-adjuvanted SCB-2019 vaccine candidate's three formulations.

6 Jun 2022

Pandemic-era changes to prescribing opioid use disorder treatment improved treatment outcomes

Pandemic-era changes to prescribing guidelines for the lifesaving drug buprenorphine led to improved treatment outcomes for patients with opioid use disorder in Philadelphia, according to a recently published study in the journal Drug and Alcohol Dependence Reports from researchers at Drexel University's Dornsife School of Public Health.

3 Jun 2022

Use of RAAS inhibitors reduced aneurysm rupture risk by 18%, finds study

A multi-center study of more than 3,000 people with high blood pressure and brain aneurysms found that the use of RAAS inhibitors, a class of blood pressure lowering medications, reduced the risk of an aneurysm rupture by 18%, according to new research published today in Hypertension, a peer-reviewed journal of the American Heart Association.

3 Jun 2022

Women are seldom informed about contraceptive failure following common anesthetic use

Women undergoing operations are not being routinely informed that a common anesthetics may make their contraception less effective, putting them at risk of an unplanned pregnancy, new research being presented at Euroanaesthesia, the annual meeting of the European Society of Anaesthesiology and Intensive Care (ESAIC) in Milan, Italy (4-6 June), suggests.

3 Jun 2022

Contraceptive pills may affect some women’s moods

Finding the right type of contraception is important. Oral contraception – also known as the pill – is the most popular and widely used method. In the June edition of Australian Prescriber, Dr Eveline Mu and Professor Jayashri Kulkarni from the Monash Alfred Psychiatry Research Centre in Melbourne write how contraceptive pills may affect some women’s moods.

3 Jun 2022

More than 4 out of 10 adults in Australia have difficulty in understanding medicine instructions

More than 4 out of 10 adults in Australia are not able to read and understand important information about their medicines. Jo Medlin, President of the Council for Adult Literacy emphasised the importance of considering health literacy in her keynote presentation at today’s National Medicine Symposium.

31 May 2022

Pharmaceutical News

Efficacy of BNT162b2 vaccine against SARS-CoV-2 Omicron sublineages and Deltacron

Study finds Moderna COVID vaccine efficacy peaks at 94% after 120 days

Safety and efficacy of tixagevimab–cilgavimab in preventing severe COVID

Molnupiravir reduces hospitalizations and deaths in at-risk, unvaccinated adults with COVID

OpenSAFELY study shows the effectiveness of Pfizer COVID booster doses

Study finds added benefits of molnupiravir for non-hospitalized COVID-19 patients

Inequalities found in oral anticoagulant prescribing to reduce stroke risk in atrial fibrillation patients

Manufacturers and suppliers influence how pharmacies buy, distribute opioid prescriptions, study finds

Misinformation clouds America’s most popular emergency contraception

California wants to slash insulin prices by becoming a drugmaker. Can it succeed?

New FR-targeting, micropinocytosis-mediated bioconjugate attacks K-Ras mutant pancreatic cancer

Safety and efficacy of SCB-2019 COVID vaccine candidate as a ChAdOx1-S booster

Pandemic-era changes to prescribing opioid use disorder treatment improved treatment outcomes

Use of RAAS inhibitors reduced aneurysm rupture risk by 18%, finds study

Women are seldom informed about contraceptive failure following common anesthetic use

Contraceptive pills may affect some women’s moods

More than 4 out of 10 adults in Australia have difficulty in understanding medicine instructions

Virtual event hosted by NPS MedicineWise focuses on improving health literacy

Highest medicinal dose of cannabidiol is driver-safe, study confirms

Topical ocular administration of progesterone could be viable treatment for retinitis pigmentosa

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News